Diagonal Bio interview

22 June 2021 - 09:10
Nasdaq First North GM Stockholm (Sweden)
Diagonal Bio AB
Diagonal Bio is developing a diagnostic platform for ultra-rapid, parallel, accurate and cost-efficient detection of any kind of pathogen - Panviral....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More